BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 32437415)

  • 41. Risk of Acute Kidney Injury Following Contrast-enhanced CT in a Cohort of 10 407 Children and Adolescents.
    Calle-Toro J; Viteri B; Ballester L; García-Perdomo HA; White A; Pradhan M; Otero HJ
    Radiology; 2023 Apr; 307(1):e210816. PubMed ID: 36472537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RCR audit of compliance with UK guidelines for the prevention and detection of acute kidney injury in adult patients undergoing iodinated contrast media injections for CT.
    Cope LH; Drinkwater KJ; Howlett DC
    Clin Radiol; 2017 Dec; 72(12):1047-1052. PubMed ID: 28842112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.
    Terrenato I; Sperati F; Musicco F; Pozzi AF; di Turi A; Caterino M; de Lutio di Castelguidone E; Setola SV; Bellomi M; Neumaier CE; Conti L; Cigliana G; Merola R; Antenucci A; Orlandi G; Giordano A; Barba M; Canitano S
    J Cell Physiol; 2018 Mar; 233(3):2572-2580. PubMed ID: 28777459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography.
    Morabito S; Pistolesi V; Benedetti G; Di Roma A; Colantonio R; Mancone M; Sardella G; Cibelli L; Ambrosino M; Polistena F; Pierucci A
    J Nephrol; 2012; 25(6):1098-107. PubMed ID: 22383347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Are iso-osmolar, as compared to low-osmolar, contrast media cost-effective in patients undergoing cardiac catheterization? An economic analysis.
    Hiremath S; Akbari A; Wells GA; Chow BJW
    Int Urol Nephrol; 2018 Aug; 50(8):1477-1482. PubMed ID: 29687326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The contrast media and nephrotoxicity following coronary revascularization by primary angioplasty for acute myocardial infarction study: design and rationale of the CONTRAST-AMI study.
    Bolognese L; Falsini G; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    J Cardiovasc Med (Hagerstown); 2010 Mar; 11(3):199-206. PubMed ID: 19829124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of Acute Kidney Injury, Dialysis, and Mortality in Patients With Chronic Kidney Disease After Intravenous Contrast Material Exposure.
    McDonald JS; McDonald RJ; Lieske JC; Carter RE; Katzberg RW; Williamson EE; Kallmes DF
    Mayo Clin Proc; 2015 Aug; 90(8):1046-53. PubMed ID: 26250726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Reed MC; Moscucci M; Smith DE; Share D; LaLonde T; Mahmood SA; D'Haem C; McNamara R; Greenbaum A; Gurm HS
    J Invasive Cardiol; 2010 Oct; 22(10):467-72. PubMed ID: 20944185
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diastolic dysfunction is associated with an increased risk of postcontrast acute kidney injury.
    Lee MJ; Park JS; Kim HH
    Medicine (Baltimore); 2019 Nov; 98(48):e17994. PubMed ID: 31770210
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
    Briguori C; Colombo A; Airoldi F; Morici N; Sangiorgi GM; Violante A; Focaccio A; Montorfano M; Carlino M; Condorelli G; Ricciardelli B
    Kidney Int; 2005 Nov; 68(5):2250-5. PubMed ID: 16221226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of intravenous hydration in preventing post-contrast acute kidney injury in patients with eGFR < 30 mL/min/1.73 m
    Yan P; Duan SB; Luo XQ; Zhang NY; Deng YH
    Eur Radiol; 2023 Dec; 33(12):9434-9443. PubMed ID: 37368109
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral hydration as a safe prophylactic measure to prevent post-contrast acute kidney injury in oncologic patients with chronic kidney disease (IIIb) referred for contrast-enhanced computed tomography: subanalysis of the oncological group of the NICIR study.
    Sebastià C; Páez-Carpio A; Guillen E; Paño B; Arnaiz JA; De Francisco ALM; Nicolau C; Oleaga L
    Support Care Cancer; 2022 Feb; 30(2):1879-1887. PubMed ID: 34613475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A systematic review of the incidence of hypersensitivity reactions and post-contrast acute kidney injury after ioversol: part 2-intra-arterial administration.
    van der Molen AJ; Dekkers IA; Bedioune I; Darmon-Kern E
    Eur Radiol; 2022 Aug; 32(8):5546-5558. PubMed ID: 35312791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
    Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ
    J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and Validation of a Risk Model for Predicting Contrast-Associated Acute Kidney Injury in Patients With Cancer: Evaluation in Over 46,000 CT Examinations.
    Gupta S; Motwani SS; Seitter RH; Wang W; Mu Y; Chute DF; Sise ME; Glazer DI; Rosner BA; Curhan GC
    AJR Am J Roentgenol; 2023 Oct; 221(4):486-501. PubMed ID: 37195792
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
    Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
    Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study.
    Lencioni R; Fattori R; Morana G; Stacul F
    Acta Radiol; 2010 Sep; 51(7):741-50. PubMed ID: 20707658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes, risk factors and health burden of contrast-induced acute kidney injury: an observational study of one million hospitalizations with image-guided cardiovascular procedures.
    Aubry P; Brillet G; Catella L; Schmidt A; Bénard S
    BMC Nephrol; 2016 Nov; 17(1):167. PubMed ID: 27821094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
    Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contrast-enhanced CT and Acute Kidney Injury: Risk Stratification by Diabetic Status and Kidney Function.
    Lee CC; Chan YL; Wong YC; Ng CJ; Chang CH; Hung CC; Su TH
    Radiology; 2023 Jun; 307(5):e222321. PubMed ID: 37278631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.